ArticleMedicine2025
Association between the atherogenic index of plasma and high risk of obstructive sleep apnea in aged person over 60: A cross-sectional analysis based on NHANES 2017 to 2020.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the association between the atherogenic index of plasma (AIP) and the high risk of obstructive sleep apnea (OSA) in aged person over 60 years, utilizing data from the National Health and Nutrition Examination Survey 2017 to 2020. A cross-sectional analysis was performed on 903 elderly participants from National Health and Nutrition Examination Survey. OSA risk was assessed using a modified STOP-Bang questionnaire. AIP was calculated as log10 (triglycerides/high-density lipoprotein cholesterol). Multivariable logistic regression models adjusted for demographics, lifestyle, and comorbidities were used to evaluate the AIP-OSA association. Subgroup analyses explored effect modifications by age, race, smoking, alcohol use, diabetes, and education. Sensitivity analyses, including quartile-based trend tests, were performed to assess the robustness of the findings. Restricted cubic splines explored potential nonlinear associations between AIP and OSA. Compared to the non-OSA High Risk Group (n = 533), the OSA High Risk group (n = 370) had significantly higher AIP (P < .05). In fully adjusted models, each 1-unit AIP increase raised OSA risk by 87% (OR = 1.87, 95% CI: 1.17-3.00, P = .0097). Subgroup analyses revealed stronger associations in individuals aged < 70 (OR = 2.50, P = .0045), alcohol consumers (OR = 2.21, P = .0019), non-diabetics (OR = 2.37, P = .0027), and non-Hispanic Black participants (OR = 5.93, P = .0014). Restricted cubic splines confirmed a linear relationship (P-overall = .0269, P-nonlinear = .471). Sensitivity analyses further supported the robustness of these findings. Elevated AIP is independently associated with a higher risk of OSA in older adults. AIP may serve as a potential biomarker for OSA risk stratification in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.